参考文献/References:
[1] Burcelin R,Serino M,Chabo C,et al.Gut microbiota and diabetes: from pathogenesis to therapeutic perspective[J].Acta Diabetol,2011,48(4):257-273.DOI:10.1007/s00592-011-0333-6.
[2] Frank DN,St Amand AL,Feldman RA,et al.Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases[J].Proc Natl Acad Sci U S A,2007,104(34):13780-13785.DOI:10.1073/pnas.0706625104.
[3] Flintoft L.Disease genomics: associations go metagenome-wide[J].Nat Rev Genet,2012,13(11):756.DOI:10.1038/nrg3347.
[4] Voreades N,Kozil A,Weir TL.Diet and the development of the human intestinal microbiome[J].Front Microbiol,2014,5:494.DOI:10.3389/fmicb.2014.00494.
[5] Musso G,Gambino R,Cassader M.Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded [J].Diabetes Care,2010,33(10):2277-2284.DOI:10.2337/dc10-0556.
[6] Qin J,Li Y,Cai Z,et al.A metagenome-wide association study of gut microbiota in type 2 diabetes[J].Nature,2012,490(7418):55-60.DOI:10.1038/nature11450.
[7] Karlsson FH,Tremaroli V,Nookaew I,et al. Gut metagenome in European women with normal, impaired and diabetic glucose control[J].Nature,2013,498(7452):99-103.DOI:10.1038/nature12198.
[8] David LA, Maurice CF, Carmody RN,et al. Diet rapidly and reproducibly alters the human gut microbiome[J].Nature,2014,505(7484):559-563.DOI:10.1038/nature12820.
[9] Wu GD,Chen J,Hoffmann C,et al.Linking long-term dietary patterns with gut microbial enterotypes[J].Science,2011,334(6052):105-108.DOI:10.1126/science.1208344.
[10] 白钰,吕全胜,马晓丽.高膳食纤维低血糖生成指数饮食对2 型糖尿病患者肠道菌群和血糖的影响研究[J].中国全科医学,2016,19(20):2469-2472.DOI:10.3969/j.issn.1007-9572.2016.20.023.
[11] Yamaguchi Y,Adachi K,Sugiyama T,et al.Association of intestinal microbiota with metabolic markers and dietary habits in patients with type 2 diabetes[J].Digestion,2016,94(2):66-72. DOI:10.1159/000447690.
[12] Clarke SF,Murphy EF,O'Sullivan O,et al.Exercise and associated dietary extremes impact on gut microbial diversity[J].Gut,2014,63(12):1913-1920.DOI:10.1136/gutjnl-2013-306541.
[13] 乔德才,陈敬,赵立平.采用DNA指纹图谱技术分析中长跑运动员肠道菌群结构特征[J].中国运动医学杂志,2004,23(5):517-521. DOI:10.3969/j.issn.1000-6710.2004.05.011.
[14] Wu H,Esteve E,Tremaroli V,et al.Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug[J].Nat Med,2017,23(7):850-858.DOI:10.1038/nm.4345.
[15] Hamer HM,Jonkers D,Venema K,et al.Review article: the role of butyrate on colonic function[J].Aliment Pharmacol Ther,2008,27(2):104-119.DOI:10.1111/j.1365-2036.2007.03562.x.
[16] Delzenne NM,Cani PD,Neyrinck AM.Modulation of glucagon-like peptide 1 and energy metabolism by inulin and oligofructose: experimental data[J].J Nutr,2007,137(11 Suppl):2547S-2551S.
[17] 张秀英, 韩学尧, 陈颖丽, 等. 阿卡波糖对糖尿病前期患者肠道菌群的影响[J]. 中华糖尿病杂志, 2012,4(增刊):31-32.
[18] 肖党生,王招娣,杨云梅,等.糖尿病患者肠道菌群研究[J].中国微生物学杂志, 2006,18(4):275-276.DOI:10.3969/j.issn.1005-376X.2006.04.006.
[19] Su B,Liu H,Li J,et al.Acarbose treatment affects the serum levels of inflammatory cytokines and the gut content of bifidobacteria in Chinese patients with type 2 diabetes mellitus[J].J Diabetes,2015,7(5):729-739.DOI:10.1111/1753-0407.12232.
[20] 刘海霞,李晶,刘奔,等.阿卡波糖对 2 型糖尿病患者粪便中双歧杆菌数量的影响[J].中华内分泌代谢杂志,2011,27(11):47-50.DOI:10.3760/cma.j.issn.1000-6699.2011.11.015.
[21] 徐杰,苏本利,关玉峰,等.阿卡波糖对糖尿病患者肠道双歧杆菌的影响[J].中国医学创新,2013,(9): 37-38. DOI:10.3969/j.issn.1674-4985.2013.09.018.
[22] Weaver GA,Tangel CT,Krause JA,et al.Acarbose enhances human colonic butyrate production[J].J Nutr,1997,127(5):717-723. DOI:10.1093/jn/127.5.717.
[23] 吕庆国, 李益, 童南伟. 阿卡波糖对 2 型糖尿病患者体重的影响[J]. 中华内科杂志, 2013,52(12):1079-1081.DOI:10.3760/cma.j.issn.0578-1426.2013.12.024.
[24] Zhang H,DiBaise JK,Zuccolo A,et al.Human gut microbiota in obesity and after gastric bypass[J].Proc Natl Acad Sci U S A,2009,106(7):2365-2370.DOI:10.1073/pnas.0812600106.
[25] Furet JP,Kong LC,Tap J,et al.Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers[J].Diabetes,2010,59(12):3049-3057.DOI:10.2337/db10-0253.
[26] Kong LC,Tap J,Aron-Wisnewsky J,et al.Gut microbiota after gastric bypass in human obesity: increased richness and associations of bacterial genera with adipose tissue genes[J].Am J Clin Nutr,2013,98(1):16-24.DOI:10.3945/ajcn.113.058743.
[27] Graessler J,Qin Y,Zhong H,et al.Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters[J].Pharmacogenomics J,2013,13(6):514-522.DOI:10.1038/tpj.2012.43.
[28] Palleja A,Kashani A,Allin KH,et al.Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistentchanges of the individual gut microbiota[J].Genome Med,2016,8(1):67.DOI:10.1186/s13073-016-0312-1.
[29] Murphy R,Tsai P,Jüllig M,et al.Differential changes in gut microbiota after gastric bypass and sleeve gastrectomy bariatric surgery vary according to diabetes remission[J].Obes Surg,2017,27(4):917-925.DOI:10.1007/s11695-016-2399-2.
相似文献/References:
[1]曾静波,王姮.2型糖尿病与自身免疫反应[J].国际内分泌代谢杂志,2007,(04):259.
[2]朱素君,谢锦桃,刘军,等.二甲双胍：2型糖尿病治疗的基础药[J].国际内分泌代谢杂志,2007,(04):280.
[3]姚霜霜,张翼飞,张志国,等.小檗碱改善代谢性疾病的肠道相关机制[J].国际内分泌代谢杂志,2014,(06):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
Yao Shuangshuang,Zhang Yifei,Zhang Zhiguo,et al.The gut-related mechanisms of berberine in the treatment of metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(04):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
[4]刘艳清 易秋艳 邵加庆.肠道菌群与肥胖和糖尿病的关系[J].国际内分泌代谢杂志,2015,(01):31.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.007]
Liu Yanqing,Yi Qiuyan,Shao Jiaqing..Relationship between gut microbiota, obesity and diabetes[J].International Journal of Endocrinology and Metabolism,2015,(04):31.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.007]
[5]姚旻 赵爱源 张宏.肠道菌群与2型糖尿病[J].国际内分泌代谢杂志,2015,(01):35.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.008]
Yao Min*,Zhao Aiyuan,Zhang Hong..Relationship between gut microbiota and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2015,(04):35.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.008]
[6]赵丽娟,徐宽枫,杨涛,等.SLC30A8和PTPRD基因多态性与南京地区中老年人群2型糖尿病的相关性研究[J].国际内分泌代谢杂志,2015,(03):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
Zhao Lijuan*,Xu Kuanfeng,Yang Tao,et al.Relationship between SLC30A8 and PTPRD gene polymorphisms and type 2 diabetes in middle aged and elderly people in Nanjing area[J].International Journal of Endocrinology and Metabolism,2015,(04):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
[7]王洁,何媛,于珮.糖尿病肾病的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
Wang Jie*,He Yuan,Yu Pei..Risk factors of diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(04):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
[8]刘帅,张萍,方毅,等.2型糖尿病合并无症状冠状动脉钙化的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
Liu Shuai*,Zhang Ping,Fang Yi,et al.Analysis of the risk factors related with asymptomatic coronary calcification for type 2 diabetic patients[J].International Journal of Endocrinology and Metabolism,2015,(04):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
[9]徐庆海,马颖,李铁马.2型糖尿病患者高甘油三酯血症-腰围表型与甲状腺功能异常的关系[J].国际内分泌代谢杂志,2015,(04):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
Xu Qinghai,Ma Ying,Li Tiema..Association of hypertriglyceridaemic-waist phenotype with thyroid dysfunction in patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(04):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
[10]潘道延,沈洁,朱筱,等.利格列汀对2型糖尿病大鼠代谢性内毒素血症的影响[J].国际内分泌代谢杂志,2015,(04):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
Pan Daoyan,Shen Jie,Zhu Xiao,et al.Effects of linagliptin on metabolic endotoxemia in type 2 diabetic rats[J].International Journal of Endocrinology and Metabolism,2015,(04):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
[11]韦晓,张少红,孙烁烁,等.肠道菌群：口服降糖药物有效性和安全性的重要靶点[J].国际内分泌代谢杂志,2023,43(01):14.[doi:10.3760/cma.j.cn121383-20210915-09040]
Wei Xiao,Zhang Shaohong,Sun Shuoshuo,et al.Gut microbiota: the important target of efficiency and safety of oral hypoglycemic agents[J].International Journal of Endocrinology and Metabolism,2023,43(04):14.[doi:10.3760/cma.j.cn121383-20210915-09040]